Latest News
Scientists seek evidence about diet and progression of MS
13th February 2019
Can diet affect multiple sclerosis? Dr Lucinda Black, MSWA funded researcher shares her latest research into patterns between the intake of specific foods and nutrients, and whether they contribute to the risk of MS.
Read More
WASO announces unique partnership with MSWA
7th February 2019
MSWA is thrilled to announce our involvement with the West Australian Symphony Orchestra for their 2019 season. This partnership recognises a shared commitment to enriching the lives of young people and families through music.
Read More
New Home Soon For Kate In Butler
17th January 2019
MSWA Member Kate Gild is very excited to be planning her move to her new home at MSWA’s new Butler facility, opening soon.
Read more about MSWA’s new $8 million high-support accommodation and services facility and what the move means for Kate.
Read More
MAVENCLAD® (cladribine tablets) for RRMS Australian Government approves PBS listing
23rd December 2018
The Hon Scott Morrison MP, today announced approval for the listing of MAVENCLAD® (cladribine tablets) for relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS) from 1 January 2019.
Read More
